COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 495

Article download: 199

IP Archives of Cytology and Histopathology Research


Inflammatory Myofibroblastic Tumor (IMT): Report of 8 cases at uncommon sites with literature review


Full Text PDF Share on Facebook Share on Twitter


Author Details : Punam Prasad Bhadani, Iffat Jamal, Umesh Kumar Bhadani, Shuchismita

Volume : 2, Issue : 4, Year : 2017

Article Page : 75-80


Suggest article by email

Abstract

Inflammatory myofibroblastic tumor (IMT) is a lesion of unknown etiology, originally described in lung but can be found at other sites also. Their presence in gall bladder, soft tissue and mesentery is rare. Eight cases of IMT is reported at abnormal sites of mesentery, gall bladder, soft tissue in thigh,  disseminated form of IMT involving gall bladder adhered with liver, pylorus and 1st part of duodenum. The characteristic histopathology and immunohistochemistry confirmed the diagnosis of IMT in these cases. Diagnosis of IMT can be challenging and need a multi-disciplinary approach for the correct diagnosis and treatment.

Keywords: Inflammatory, Myofibroblastic, Tumor, Gall bladder, Pylorus, Immunohistochemistry

How to cite : Bhadani P P, Jamal I, Bhadani U K, Shuchismita, Inflammatory Myofibroblastic Tumor (IMT): Report of 8 cases at uncommon sites with literature review. IP Arch Cytol Histopathol Res 2017;2(4):75-80

Copyright © 2017 by author(s) and IP Arch Cytol Histopathol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)